Rocket Pharmaceuticals, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | $-19.6M | $-7.6M | $-68.0M | $-9.5M |
| Depreciation & Amortization | — | — | — | — |
| Depreciation | $204.0K | $67.0K | $45.0K | $0 |
| Amortization | — | — | — | — |
| Stock-Based Compensation | $1.3M | $274.0K | $2.4M | $177.0K |
| Net Cash from Operating Activities | $-16.0M | $-5.5M | $-17.4M | $-9.7M |
| Investing Activities | ||||
| Capital Expenditures | $760.0K | $335.0K | $412.0K | — |
| Business Acquisitions | — | — | — | — |
| Net Cash from Investing Activities | $-760.0K | $-335.0K | — | — |
| Financing Activities | ||||
| Dividends Paid | — | — | — | — |
| Stock Repurchases | $0 | $0 | — | — |
| Net Cash from Financing Activities | $25.4M | $16.0K | — | — |
| Net Change in Cash | $48.9M | $-50.2M | $76.4M | $-9.2M |
| Free Cash Flow | $-16.7M | $-5.8M | $-17.8M | — |